全文获取类型
收费全文 | 514183篇 |
免费 | 33263篇 |
国内免费 | 614篇 |
专业分类
耳鼻咽喉 | 6894篇 |
儿科学 | 16842篇 |
妇产科学 | 13528篇 |
基础医学 | 85029篇 |
口腔科学 | 14473篇 |
临床医学 | 44346篇 |
内科学 | 93629篇 |
皮肤病学 | 12157篇 |
神经病学 | 36185篇 |
特种医学 | 18454篇 |
外国民族医学 | 63篇 |
外科学 | 77096篇 |
综合类 | 8471篇 |
一般理论 | 118篇 |
预防医学 | 38970篇 |
眼科学 | 12136篇 |
药学 | 40542篇 |
中国医学 | 1006篇 |
肿瘤学 | 28121篇 |
出版年
2018年 | 4935篇 |
2015年 | 4510篇 |
2014年 | 6063篇 |
2013年 | 9547篇 |
2012年 | 12874篇 |
2011年 | 14282篇 |
2010年 | 8304篇 |
2009年 | 7782篇 |
2008年 | 13699篇 |
2007年 | 14703篇 |
2006年 | 14944篇 |
2005年 | 14366篇 |
2004年 | 14050篇 |
2003年 | 13399篇 |
2002年 | 13270篇 |
2001年 | 24070篇 |
2000年 | 25079篇 |
1999年 | 20557篇 |
1998年 | 5426篇 |
1997年 | 4705篇 |
1996年 | 5041篇 |
1995年 | 4625篇 |
1994年 | 4318篇 |
1993年 | 4137篇 |
1992年 | 15728篇 |
1991年 | 16310篇 |
1990年 | 16424篇 |
1989年 | 15796篇 |
1988年 | 14575篇 |
1987年 | 14419篇 |
1986年 | 13597篇 |
1985年 | 12975篇 |
1984年 | 9627篇 |
1983年 | 8247篇 |
1982年 | 4559篇 |
1981年 | 4229篇 |
1979年 | 9418篇 |
1978年 | 6855篇 |
1977年 | 5772篇 |
1976年 | 5602篇 |
1975年 | 6396篇 |
1974年 | 7634篇 |
1973年 | 7130篇 |
1972年 | 6960篇 |
1971年 | 6685篇 |
1970年 | 6172篇 |
1969年 | 5888篇 |
1968年 | 5559篇 |
1967年 | 5012篇 |
1966年 | 4450篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
I. R. Reid 《Journal of internal medicine》2015,277(6):690-706
There is an increasing number of effective therapies for fracture prevention in adults at risk of osteoporosis. However, shortcomings in the evidence underpinning our management of osteoporosis still exist. Evidence of antifracture efficacy in the groups of patients who most commonly use calcium and vitamin D supplements is lacking, the safety of calcium supplements is in doubt, and the safety and efficacy of high doses of vitamin D give cause for concern. Alendronate, risedronate, zoledronate and denosumab have been shown to prevent spine, nonspine and hip fractures; in addition, teriparatide and strontium ranelate prevent both spine and nonspine fractures, and raloxifene and ibandronate prevent spine fractures. However, most trials provide little information regarding long‐term efficacy or safety. A particular concern at present is the possibility that oral bisphosphonates might cause atypical femoral fractures. Observational data suggest that the incidence of this type of fracture increases steeply with duration of bisphosphonate use, resulting in concern that the benefit–risk balance may become negative in the long term, particularly in patients in whom the osteoporotic fracture risk is not high. Therefore, reappraisal of ongoing use of bisphosphonates after about 5 years is endorsed by expert consensus, and ‘drug holidays’ should be considered at this time. Further studies are needed to guide clinical practice in this area. 相似文献
12.
R. Di Raimondo J. Sanz-Esporrn R. Pl I. Sanz-Martn F. Luengo F. Vignoletti J. Nuez Mariano Sanz 《Clinical oral investigations》2020,24(7):2351-2361
To evaluate the changes in alveolar contour after guided bone regeneration (GBR) with two different combinations of biomaterials in dehiscence defects arou 相似文献
13.
14.
Feasibility and Diagnostic Potential of Pulmonary Transit Time Measurement by Contrast Echocardiography: A Pilot Study
下载免费PDF全文
![点击此处可从《Echocardiography (Mount Kisco, N.Y.)》网站下载免费的PDF全文](/ch/ext_images/free.gif)
15.
16.
17.
18.
M. Zamparas V.C. Kapsalis G.L. Kyriakopoulos K.G. Aravossis A.E. Kanteraki A. Vantarakis I.K. Kalavrouziotis 《Sustainable Chemistry and Pharmacy》2019
At this study a multi-criteria model was developed to examine the available procedures, techniques and methods of handling infectious waste in the large healthcare unit of University Regional General Hospital of Patras, Western Greece. Particularly, this study examined the: a) current legislation and Directives issued for medical waste management at Greece and among the other EU-members, b) contribution of healthcare wastes (HCW) generation rate on social and economic parameters in selected European countries, c) available procedures, techniques, and methods upon the disposal of infectious wastes at the healthcare studied, and, d) propositions for integrated management of such hazardous wastes. Specifically, the Analytic Hierarchy Process (AHP) methodology was applied under pair wise comparison matrices in two stages: 1) the scale factors and the indicators, and 2) the criteria and their sub–criteria. The assessment of these pair wise matrices included the indicators and the sub–criteria. Subsequently, two pair wise comparison matrices, upon a) the “Fulfillment of environmental objectives” indicator and b) the “Energy consumption” sub criterion, were denoted. The AHP methodology yielded good results; however there is still space of improving the environmental performance. The normalized relative weights obtained for the criteria and sub criteria motivated specific actions that have to be handled. Particularly, the results indicated a very good value in environmental management criteria due the values obtained for the commitment towards the environmental policy standards and the waste management procedures. However, further improvements on staff awareness (such as development programs to enhance sensitivity) and more green purchasing suppliers, should be further addressed. 相似文献
19.
20.
Y. Ermias I.A. Morgan K.M. Curtis M.K. Whiteman L.G. Horton L.B. Zapata 《Contraception》2019,99(5):300-305
ObjectiveIdentify factors associated with healthcare providers' frequency of depot medroxyprogesterone acetate (DMPA) provision to adolescents.Study designWe analyzed data from surveys mailed to a nationally representative sample of public-sector providers and office-based physicians (n=1984). We estimated adjusted odds ratios (aORs) and 95% confidence intervals (CIs) of factors associated with frequent DMPA provision to adolescents in the past year.ResultsAlthough most providers (>95%) considered DMPA safe for adolescents, fewer reported frequent provision (89% of public-sector providers; 64% of office-based physicians). Among public-sector providers, factors associated with lower odds of frequent provision included working in settings without Title X funding (aOR 0.44, 95% CI 0.30–0.64), reporting primary care as their primary clinical focus versus reproductive or adolescent health (aOR 0.42, 95% CI 0.28–0.61), and providing fewer patients with family planning services. Among office-based physicians, factors associated with lower odds of frequent provision included specializing in obstetrics/gynecology (aOR 0.50, 95% CI 0.27–0.91) and family medicine (aOR 0.21, 95% CI 0.09–0.47) versus adolescent medicine, completing training ≥15 versus <5 years ago (aOR 0.27, 95% CI 0.09–0.83), and reporting that 0–24% of patients pay with Medicaid or other government healthcare assistance versus ≥50% (aOR 0.23, 95% CI 0.09–0.61). The reason most commonly reported by providers for infrequent DMPA provision was patient preference for another method.ConclusionsWhile most providers reported frequently providing DMPA to adolescents, training on evidence-based recommendations for contraception, focused on subgroups of providers with lower odds of frequent DMPA provision, may increase adolescents' access to contraception.ImplicationsAlthough >95% of providers considered depot medroxyprogesterone (DMPA) a safe contraceptive for adolescents, only 89% of public-sector providers and 64% of office-based physicians reported frequently providing DMPA to adolescents. Provider training on evidence-based recommendations for contraception counseling and provision may increase adolescents' access to DMPA and all methods of contraception. 相似文献